Bone loss prevention in ovariectomized rats using stable amorphous calcium carbonate

作者: Galit Shaltiel , Elad Bar-David , Oren E. Meiron , Eitan Waltman , Assaf Shechter

DOI: 10.4236/HEALTH.2013.57A2003

关键词:

摘要: In assessing the relationship between calcium supplementation and maintaining bone mass or reducing risk of fracture, effectiveness of has never been decisive. Freshwater crayfish rely on amorphous calcium carbonate (ACC), an instable polymorph carbonate, as main mineral in exoskeleton in temporary storage organ, gastrolith. Inspired by model, we have previously shown increase bioavailability in rats administered with synthetic stable ACC vs. crystalline carbonate (CCC). The current study compared effects derived from either gastrolith those calcium, found in commercial CCC calciumcitrate supplements, in a loss prevention model. Rats were subjected to either sham ovariectomy (OVX) operation (n~20/ group) followed by administration food pellets supplemented with 0.5% from source over 12 weeks. Micro-computed tomography (μCT) histomorphometric analyses revealed both treatments, manifested morphometric parameters, CCC- and citrate-treated groups. Both treatments resulted formation tibia cancellous bone, indicated dynamic histomorphometry citrate treatments. Levels urine deoxypyridinoline (DPD), suggested an anti-resorptive effect ACC, which was also only treatment that led significant vertebral mechanical strength, supported by μCT analysis topology orientation parameters trabeculae. To our knowledge, such levels bone loss supplements never been reported. These findings thus suggest potential natural (crayfish gastrolith) and, greater extent, sources for prevention of metabolic disorders possibly osteoporotic processes.

参考文章(45)
Andrew Willan, Gordon Guyatt, Ann Cranney, Peter Tugwell, Bruce Weaver, Lauren Griffith, Alexandra Papaioannou, George Wells, David Henry, Jonathan Adachi, Dennis Black, Nicole Zytaruk, Joan Peterson, Vivian Robinson, Beverley Shea, V. Hormone Replacement, Jonathan, Meta-Analyses of Therapies for Postmenopausal Osteoporosis ,(2002)
B Dawson-Hughes, Calcium supplementation and bone loss: a review of controlled clinical trials. The American Journal of Clinical Nutrition. ,vol. 54, pp. 274- 280 ,(1991) , 10.1093/AJCN/54.1.274S
Ai Sato, Seiji Nagasaka, Kazuo Furihata, Shinji Nagata, Isao Arai, Kazuko Saruwatari, Toshihiro Kogure, Shohei Sakuda, Hiromichi Nagasawa, Glycolytic intermediates induce amorphous calcium carbonate formation in crustaceans. Nature Chemical Biology. ,vol. 7, pp. 197- 199 ,(2011) , 10.1038/NCHEMBIO.532
Mohammad Shahnazari, Berdine R. Martin, Leecole L. Legette, Pamela J. Lachcik, Jo Welch, Connie M. Weaver, Diet Calcium Level but Not Calcium Supplement Particle Size Affects Bone Density and Mechanical Properties in Ovariectomized Rats Journal of Nutrition. ,vol. 139, pp. 1308- 1314 ,(2009) , 10.3945/JN.108.101071
Mohammad Shahnazari, Wei Yao, Bob Wang, Brian Panganiban, Robert O Ritchie, Yolanda Hagar, Nancy E Lane, Differential maintenance of cortical and cancellous bone strength following discontinuation of bone-active agents. Journal of Bone and Mineral Research. ,vol. 26, pp. 569- 581 ,(2011) , 10.1002/JBMR.249
C.H. Turner, D.B. Burr, Basic Biomechanical Measurements of Bone: A Tutorial Bone. ,vol. 14, pp. 595- 608 ,(1993) , 10.1016/8756-3282(93)90081-K
Jin-Woo Park, Youn-Jeong Kim, Je-Hee Jang, Chang-Hyeon An, MC3T3-E1 cell differentiation and in vivo bone formation induced by phosphoserine Biotechnology Letters. ,vol. 33, pp. 1473- 1480 ,(2011) , 10.1007/S10529-011-0565-0